Literature DB >> 2907492

In vitro degradation of opioid peptides by human placental aminopeptidase M.

M Furuhashi1, S Mizutani, O Kurauchi, M Kasugai, O Narita, Y Tomoda.   

Abstract

The degradation of opioid peptides by human placental aminopeptidase M was studied by measuring liberated amino acids by high performance liquid chromatography. The purified placental aminopeptidase M actively degraded Met-enkephalin (Met-Enk) and Leu-enkephalin (Leu-Enk) completely into constituent 5 amino acids. The activities as a function of tyrosine liberation were observed for Met-Enk followed by Leu-Enk, beta-neoendorphin, dynorphin, and beta-endorphin.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2907492     DOI: 10.1055/s-0029-1210807

Source DB:  PubMed          Journal:  Exp Clin Endocrinol        ISSN: 0232-7384


  5 in total

1.  Development of Synthetic Aminopeptidase N/CD13 Inhibitors to Overcome Cancer Metastasis and Angiogenesis.

Authors:  Li Su; Jiangying Cao; Yuping Jia; Xiaonan Zhang; Hao Fang; Wenfang Xu
Journal:  ACS Med Chem Lett       Date:  2012-09-21       Impact factor: 4.345

2.  Identification and characterization of aminopeptidases from Aplysia californica.

Authors:  W Bawab; E Querido; P Crine; L DesGroseillers
Journal:  Biochem J       Date:  1992-09-15       Impact factor: 3.857

3.  Gene expression profiles alteration after infection of virus, bacteria, and parasite in the Olive flounder (Paralichthys olivaceus).

Authors:  Gyu-Hwi Nam; Anshuman Mishra; Jeong-An Gim; Hee-Eun Lee; Ara Jo; Dahye Yoon; Ahran Kim; Woo-Jin Kim; Kung Ahn; Do-Hyung Kim; Suhkmann Kim; Hee-Jae Cha; Yung Hyun Choi; Chan-Il Park; Heui-Soo Kim
Journal:  Sci Rep       Date:  2018-12-24       Impact factor: 4.379

4.  Extracellular cysteines define ectopeptidase (APN, CD13) expression and function.

Authors:  Beate Firla; Marco Arndt; Karin Frank; Ute Thiel; Siegfried Ansorge; Michael Täger; Uwe Lendeckel
Journal:  Free Radic Biol Med       Date:  2002-04-01       Impact factor: 7.376

Review 5.  Aminopeptidase-N/CD13 (EC 3.4.11.2) inhibitors: chemistry, biological evaluations, and therapeutic prospects.

Authors:  Brigitte Bauvois; Daniel Dauzonne
Journal:  Med Res Rev       Date:  2006-01       Impact factor: 12.944

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.